SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-023571
Filing Date
2024-06-12
Accepted
2024-06-12 14:05:49
Documents
78
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form20-f.htm   iXBRL 20-F 1810457
2 ex12-1.htm EX-12.1 17464
3 ex12-2.htm EX-12.2 17426
4 ex13-1.htm EX-13.1 6473
5 ex13-2.htm EX-13.2 6536
6 ex15a.htm EX-15.A 57209
7 ex15b.htm EX-15.B 63545
8 form20-f_001.jpg GRAPHIC 5232
9 form20-f_002.jpg GRAPHIC 8970
  Complete submission text file 0001493152-24-023571.txt   6383276

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE avcr-20231231.xsd EX-101.SCH 51545
11 XBRL CALCULATION FILE avcr-20231231_cal.xml EX-101.CAL 60881
12 XBRL DEFINITION FILE avcr-20231231_def.xml EX-101.DEF 129483
13 XBRL LABEL FILE avcr-20231231_lab.xml EX-101.LAB 326239
14 XBRL PRESENTATION FILE avcr-20231231_pre.xml EX-101.PRE 234639
82 EXTRACTED XBRL INSTANCE DOCUMENT form20-f_htm.xml XML 1115191
Mailing Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2
Business Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2 604-687-2038
Avricore Health Inc. (Filer) CIK: 0001355736 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-51848 | Film No.: 241038072
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)